Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis ß-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of ß-lactam-ß-lactamase inhibitor combinations.
Antimicrob Agents Chemother
; 57(12): 6085-96, 2013 Dec.
Article
en En
| MEDLINE
| ID: mdl-24060876
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Beta-Lactamasas
/
Tienamicinas
/
Ácido Clavulánico
/
Inhibidores de beta-Lactamasas
/
Mycobacterium tuberculosis
/
Antituberculosos
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
2013
Tipo del documento:
Article